Full US Food and Drug Administration approval of the Pfizer/BioNTech COVID-19 vaccine is "imminent," a senior federal official told CNN on Friday -- but said no date has been mentioned. A person ...
Pfizer/BioNTech has initiated its application to the US Food and Drug Administration for full FDA approval of its Covid-19 vaccine for people ages 16 and older, the companies said Friday. This is the ...
WASHINGTON — U.S. regulators approved updated covid-19 shots Wednesday but limited their use for many Americans — and removed one of the two vaccines available for young children. Additionally, Pfizer ...
Pfizer says COVID vaccine protection lasts at least 6 months; Company can now seek full FDA approval
The ongoing Phase 3 clinical trial of Pfizer/BioNTech's coronavirus vaccine confirms its protection lasts at least six months after the second dose, the companies said Thursday. The companies can now ...
The 2025-2026 COVID-19 vaccine formulation targets the SARS-CoV-2 sublineage LP.8.1, in line with FDA guidance to more closely match circulating strains1 Shipping of the LP.8.1-adapted vaccine will ...
Click to share on Facebook (Opens in new window) Facebook Click to share on X (Opens in new window) X WASHINGTON (AP) — U.S. regulators approved updated COVID-19 shots Wednesday but limited their use ...
WASHINGTON (AP) — U.S. regulators approved updated COVID-19 shots Wednesday but limited their use for many Americans — and removed one of the two vaccines available for young children. The new shots ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback